Alaunos Therapeutics, Inc. (TCRT) Insider Trading

Name: Alaunos Therapeutics, Inc. (TCRT) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Oct 8, 2026): Holger Weis (CEO): Grant/Award of 23,564 shares, $17.5K.

Get alerted when insiders trade TCRT

Every alert includes an AI-written analysis of the filing, plus news and market context.

Email address

Loading company data...

Beta

Loading company details...

Beta